Document is current
Any future updates will be listed below
-
Authors
Spagnolo, Federico
Molchanova, Nataliia
Cuadra, Meritxell Bach
Ocampo-Pineda, Mario
Melie-Garcia, Lester
Granziera, Cristina
Andrearczyk, Vincent
Depeursinge, Adrien
- License Information
-
More Information
Article History
Received: 22 October 2024
Accepted: 13 January 2026
First Online: 2 February 2026
Declarations
:
: The University Hospital Basel (USB) and the Research Center for Clinical neuroimmunology and Neuroscience (RC2NB), as the employers of Cristina Granziera, have received the following fees which were used exclusively for research support from Siemens, GeNeuro, Genzyme-Sanofi, Biogen, Roche. They also have received advisory board and consultancy fees from Actelion, Genzyme-Sanofi, Novartis, GeNeuro, Merck, Biogen and Roche; as well as speaker fees from Genzyme-Sanofi, Novartis, GeNeuro, Merck, Biogen and Roche.
